Rankings
▼
Calendar
▼
IPSC Q1 2020 Earnings Report — Century Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Century Therapeutics, Inc.
IPSC
Q1 2020 Earnings
Reported March 30, 2020
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q1 2020
Q4 2019
Q1 2019
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$10M
—
—
—
—
EPS (Diluted)
$-0.23
—
—
—
—
Free Cash Flow
-$10M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$8M
Selling & Marketing
$0
General & Administrative
$2M
SG&A Expenses
$2M
Other Expenses
$0
Operating Expenses
$10M
Cost & Expenses
$10M
OPERATING INCOME
-$10M
Interest Income
$320.0K
Interest Expense
$0
Other Income/Expenses
$320.0K
INCOME BEFORE TAX
-$10M
Income Tax Expense
$0
Net Income from Continuing Ops
-$10M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$10M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$10M
D&A
$200.0K
EBIT
-$10M
EBITDA
-$9M
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$10M
Depreciation & Amortization
$200.0K
Stock-Based Compensation
$221.0K
Deferred Income Tax
$0
Other Non-Cash Items
$59.0K
Change in Working Capital
$2M
OPERATING CASH FLOW
-$7M
Capital Expenditure
-$3M
Acquisitions (Net)
$0
Purchases of Investments
-$1M
Sales/Maturities of Investments
$0
Other Investing Activities
$0
NET CASH FROM INVESTING
-$4M
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$0
NET CASH FROM FINANCING
$0
FREE CASH FLOW
-$10M
Net Change in Cash
-$11M
marketcaparena.com
← FY 2020
IPSC Overview
Q2 2020 →